These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. Amani A, York P, Chrystyn H, Clark BJ. AAPS PharmSciTech; 2010 Sep; 11(3):1147-51. PubMed ID: 20652776 [Abstract] [Full Text] [Related]
24. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Salama RO, Traini D, Chan HK, Young PM. Eur J Pharm Biopharm; 2008 Sep; 70(1):145-52. PubMed ID: 18534832 [Abstract] [Full Text] [Related]
27. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Respir Care; 2010 Jul; 55(7):845-51. PubMed ID: 20587095 [Abstract] [Full Text] [Related]
28. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Kaur R, Garg T, Das Gupta U, Gupta P, Rath G, Goyal AK. Artif Cells Nanomed Biotechnol; 2016 Jul; 44(1):182-7. PubMed ID: 24992699 [Abstract] [Full Text] [Related]
29. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. Osman R, Kan PL, Awad G, Mortada N, El-Shamy AE, Alpar O. Int J Pharm; 2011 Apr 15; 408(1-2):257-65. PubMed ID: 21335080 [Abstract] [Full Text] [Related]
30. Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Nasr M, Taha I, Hathout RM. Drug Deliv; 2013 Nov 15; 20(8):311-8. PubMed ID: 24079347 [Abstract] [Full Text] [Related]
36. Characterization of different vitamin E carriers intended for pulmonary drug delivery. Laouini A, Andrieu V, Vecellio L, Fessi H, Charcosset C. Int J Pharm; 2014 Aug 25; 471(1-2):385-90. PubMed ID: 24939617 [Abstract] [Full Text] [Related]
37. Polymer-Lipid Microparticles for Pulmonary Delivery. Eleftheriadis GK, Akrivou M, Bouropoulos N, Tsibouklis J, Vizirianakis IS, Fatouros DG. Langmuir; 2018 Mar 20; 34(11):3438-3448. PubMed ID: 29486562 [Abstract] [Full Text] [Related]
38. Nanomedicine in pulmonary delivery. Mansour HM, Rhee YS, Wu X. Int J Nanomedicine; 2009 Mar 20; 4():299-319. PubMed ID: 20054434 [Abstract] [Full Text] [Related]
39. Pulmonary formulations: what remains to be done? Weers JG, Bell J, Chan HK, Cipolla D, Dunbar C, Hickey AJ, Smith IJ. J Aerosol Med Pulm Drug Deliv; 2010 Dec 20; 23 Suppl 2():S5-23. PubMed ID: 21133800 [Abstract] [Full Text] [Related]